Long-term control of congestive heart failure with captopril.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  American Journal of Cardiology

• Publication date

  1982-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(82)90366-6PMID 6803563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive measurement of cardiopulmonary blood volume. Evaluation of the centroid method.

  1981cited by this paper
• Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.

  1981cited by this paper
• Hyperkinetic circulation associated with captopril therapy for congestive heart failure.

  1981cited by this paper
• Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.

  1981cited by this paper
• Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor

  1980cited by this paper
• Central and Peripheral Hemodynamic Effects of Angiotensin Inhibition in Patients with Refractory Congestive Heart Failure

  1980cited by this paper
• Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

  1980cited by this paper
• The pathogenesis of peripheral cardiac edema.

  1980cited by this paper
• Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure

  1980cited by this paper
• Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure.

  1980cited by this paper
• Venous delay, a major source of error in isotopic cardiac output determination.

  1979cited by this paper
• Effects of the Oral Converting Enzyme Inhibitor, SQ 14225, in a Model of Low Cardiac Output in Dogs

  1979cited by this paper
• Improvement of chronic congestive heart-failure by oral captopril.

  1979cited by this paper
• Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

  1979cited by this paper
• Automated computer program for radionuclide cardiac output determination.

  1979cited by this paper
• Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure.

  1979cited by this paper
• High renin in heart failure: a manifestation of hyponatremia.

  1979cited by this paper
• Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.

  1979cited by this paper
• Vasodilator therapy.

  1978cited by this paper
• Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure

  1978cited by this paper
• Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.

  1978cited by this paper
• The Renin‐Angiotensin‐Aldosterone System in Rabbits with Congestive Heart Failure Produced by Aortic Constriction

  1977cited by this paper
• Evaluation of ventricular function by radioisotopic technics.

  1977cited by this paper
• Renin-angiotensin-aldosterone system in rabbits with thoracic caval constriction.

  1977cited by this paper
• Infective endocarditis: a clinical overview.

  1977cited by this paper
• The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.

  1976cited by this paper
• Vasodilator Therapy for Chronic Left Ventricular Failure

  1976cited by this paper
• Facilitation of Adrenergic Transmission by Locally Generated Angiotensin II in Rat Mesenteric Arteries

  1976cited by this paper
• Mechanisms regulating renin release.

  1976cited by this paper
• Dissociation Between Renin and Arterial Pressure Responses to Beta‐Adrenergic Blockade in Human Essential Hypertension

  1975cited by this paper
• Aldosterone and its regulation during diuresis in patients with gross congestive heart failure.

  1974cited by this paper
• Treatment of refractory heart failure with infusion of nitroprusside.

  1974cited by this paper
• The control of renin release.

  1973cited by this paper
• Effects of Angiotensin Infusion on Catecholamine Uptake and Reactivity in Blood Vessels

  1971cited by this paper
• Central vasomotor stimulation by angiotensin.

  1970cited by this paper
• Renin relationships in congestive cardiac failure, treated and untreated.

  1970cited by this paper
• Compensatory mechanisms in congestive heart failure--the role of the peripheral resistance vessels.

  1970cited by this paper
• Hepatic Clearance of Renin in Canine Experimental Models for Low‐ and High‐Output Heart Failure

  1969cited by this paper
• Endocrine factors in congestive heart failure.

  1968cited by this paper
• Plasma renin and angiotensinogen levels in pathological states associated with oedema.

  1968cited by this paper
• Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man.

  1966cited by this paper
• INCREASED RESPONSE TO SYMPATHETIC STIMULATION IN THE CUTANEOUS VASCULATURE IN PRESENCE OF ANGIOTENSIN.

  1965cited by this paper
• Evidence that a humoral agent stimulates the adrenal cortex to secrete aldosterone in experimental secondary hyperaldosteronism.

  1959cited by this paper
• Peripheral Venoconstriction During Acceleration and Orthostasis

  1956cited by this paper
• Mechanisms of Fluid and Electrolyte Retention in Experimental Preparations in Dogs: III. Effect of Adrenalectomy and Subsequent Desoxycorticosterone Acetate Administration on Ascites Formation

  1953cited by this paper
• The pathogenesis of peripheral cardiac edema.

  1947cited by this paper
• Concentration of renin in renal venous blood in patients with chronic heart failure.

  1946cited by this paper

• Cardioprotective Role of Captopril: From Basic to Applied Investigations

  2025cites this paper
• Captopril: An Update Review of its Pharmacological Properties and Therapeutic Efficacy in Congestive Heart Failure

  2012cites this paper
• [Acute and long-term effect of captopril in severe chronic heart failure].

  2008cites this paper
• Blood volume assessment in the diagnosis and treatment of chronic heart failure.

  2007cites this paper
• Modification of left ventricular geometry and function during healing after acute myocardial infarction

  2006cites this paper
• Human Cardiac Muscle In Vitro

  2005cites this paper
• Captopril in children with dilated cardiomyopathy: Acute and long-term effects in a prospective study of hemodynamic and hormonal effects

  2005cites this paper
• Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes.

  2004cites this paper
• Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

  2004cites this paper
• The regulation and measurement of plasma volume in heart failure.

  2002cites this paper
• Angiotensin II provokes cesium-induced ventricular tachyarrhythmias.

  2001cites this paper
• The 5-HT4 Receptor in the Adrenal Gland

  1998cites this paper
• Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.

  1997cites this paper
• Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.

  1997cites this paper
• An iotensin=Convertin in t I! e Clinical Setting o t Enzyme Inhibitors Chiwnic Congestive Heart Failure

  1995cites this paper
• Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure.

  1995cites this paper
• Hemodynamic effects of inhibitors of the renin-angiotensin system.

  1994cites this paper
• Radionuclide Methods for the Evaluation of Ventricular Function and Thrombolytic Therapy

  1994cites this paper
• Fluid and electrolyte disorders in congestive heart failure.

  1994cites this paper
• Antiatherosclerotic Effects of the Angiotensin‐Converting Enzyme Inhibitors Captopril and Fosinopril in Hypercholesterolemic Minipigs

  1994cites this paper
• Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.

  1992cites this paper
• Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.

  1991cites this paper
• Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements.

  1991cites this paper
• Non‐invasive evaluation of long‐term cardiac effects of captopril in systemic sclerosis

  1991cites this paper
• Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril.

  1990cites this paper
• Inotropic effects of angiotensin II on human cardiac muscle in vitro.

  1990cites this paper
• Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats

  1990cites this paper
• The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation.

  1990cites this paper
• Ceranapril (SQ 29,852), an Orally Active Inhibitor of Angiotensin Converting Enzyme (ACE)

  1990cites this paper
• Blood Pressure Lowering and Renal Hemodynamic Effects of Fosinopril in Conscious Animal Models

  1990cites this paper
• Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.

  1989cites this paper
• Fosinopril, a Phosphinic Acid Inhibitor of Angiotensin I Converting Enzyme: In Vitro and Preclinical In Vivo Pharmacology

  1989cites this paper
• Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting Enzyme

  1989cites this paper
• Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.

  1989cites this paper
• The renin-angiotensin system and treatment of heart failure.

  1988cites this paper
• Diuretic therapy in children

  1988cites this paper
• [Hemodynamic effect of captopril in children with dilated cardiomyopathy].

  1988cites this paper
• Biology of a novel class of potent long‐acting angiotensin converting enzyme inhibitors: the acyl lysinamido phosphonates

  1988cites this paper
• Effects of captopril on survival in patients with heart failure.

  1988cites this paper
• Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

  1988cites this paper
• Captopril Versus Digoxin in Mild‐Moderate Chronic Heart Failure: A Crossover Study

  1987cites this paper
• Haemodynamics at rest and during isometric exercise under long-term treatment with captopril in dilated and ischaemic cardiomyopathy.

  1987cites this paper
• Effects of Single Doses of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers

  1987cites this paper
• Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.

  1987cites this paper
• Converting-enzyme inhibition and coronary blood flow.

  1987cites this paper
• Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.

  1987cites this paper
• Angiotensin-converting enzyme inhibitors.

  1987cites this paper
• Enalapril in chronic heart failure, a double-blind placebo-controlled study.

  1986cites this paper
• Intravenous captopril treatment in patients with severe cardiac failure.

  1986cites this paper
• Restoration of Cardiac Function and Structure by Converting Enzyme Inhibition Possibilities and Limitations of Long‐Term Treatment in Hypertension and Heart Failure

  1986cites this paper
• 2 – Hemodynamic Consequences of Myocardial Infarction and the Role of Vasodilators in Acute and Chronic Management

  1986cites this paper
• Converting Enzyme Inhibition: Therapy for Chronic Heart Failure

  1986cites this paper
• Captopril in heart failure: a double-blind study of the effects on renal function.

  1986cites this paper
• The Treatment of Heart Failure

  1986cites this paper
• [Short and intermediate-term hemodynamic study at rest and during exercise of cardiac insufficiency treated by captopril].

  1986cites this paper
• Hämodynamik vor und sechs Monate nach Captopril bei Herzinsuffizienz

  1986cites this paper
• Idiopathic hypovolemia.

  1986cites this paper
• Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.

  1985cites this paper
• [Rest and effort hemodynamics during long-term treatment of dilated and ischemic cardiomyopathy with captopril].

  1985cites this paper
• [Conversion enzyme inhibitors in the treatment of chronic congestive cardiac failure. Physiopathologic bases of their use].

  1985cites this paper
• Recent advances in the management of chronic heart failure.

  1985cites this paper
• Prospectives for angiotensin converting enzyme inhibition in heart diseases.

  1985cites this paper
• Hemodynamic and metabolic effects of enalapril in patients with heart failure

  1985cites this paper
• Effects of cardiac medications on ventricular performance: emphasis on evaluation with radionuclide angiography.

  1985cites this paper
• The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers

  1985cites this paper
• The use of captopril in the management of cardiac failure.

  1984cites this paper
• The Kidney as an Endocrine Organ

  1984cites this paper
• Long-term captopril therapy for chronic congestive heart failure.

  1984cites this paper
• [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].

  1984cites this paper
• Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure

  1984cites this paper
• [Captopril in cardiac insufficiency. Immediate and long-term effects].

  1984cites this paper
• Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).

  1984cites this paper
• Drugs and the heart four years on.

  1984cites this paper
• Advances in feline cardiomyopathy.

  1984cites this paper
• [Vasodilator agents in the treatment of cardiac insufficiency].

  1984cites this paper
• Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

  1984cites this paper
• Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

  1984cites this paper
• Captopril in heart failure. A double blind controlled trial.

  1984cites this paper
• [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].

  1984cites this paper
• Der Einsatz von Vasodilatatoren bei chronischer Herzinsuffizienz

  1984cites this paper
• Captopril in congestive heart failure resistant to other vasodilators.

  1984cites this paper
• Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.

  1983cites this paper
• Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.

  1983cites this paper
• Cardiac factors in response to antihypertensive treatment.

  1983cites this paper
• Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.

  1983cites this paper
• Further experience with long-term captopril therapy in severe refractory congestive heart failure.

  1983cites this paper
• The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.

  1983cites this paper
• Pathogenesis and management of congestive heart failure--revisited.

  1983cites this paper
• [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].

  1983cites this paper
• Captopril in heart failure with renal disease.

  1983cites this paper
• Antihypertensive Activity of SCH 31846, a Non‐Sulfhydryl Angiotensin‐Converting Enzyme Inhibitor

  1983cites this paper
• Captopril in refractory heart failure: clinical and hemodynamic observations.

  1983cites this paper
• Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.

  1983cites this paper
• [Treatment of chronic cardiac insufficiency in 1983].

  1983cites this paper
• Angiotensin‐Converting Enzyme Inhibitory Activity of SCH 31846, a New Non‐Sulfhydryl Inhibitor

  1983cites this paper
• [Congestive cardiomyopathy: value of short and long-term vasodilator treatment and prognosis].

  1983cites this paper
• Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.

  1983cites this paper
• Long-term captopril therapy in congestive heart failure: serial hemodynamic and echocardiographic changes.

  1982cites this paper
• Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.

  1982cites this paper
• Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.

  1982cites this paper